Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression
Detection Principle
ImmunoAssay-Antibody
Target
IgM
Testing Method Category
GICA
Testing Method
SARS-CoV-2 IgM GICA kit (Shanghai Outdo Biotech Co., China)
Reported Performance
Positive rate: 82.2% (from the RT-qPCR confirmed positive cases)
Sample Size
185 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements